RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.

Vaccination coverage in the Netherlands rose more sharply this week than in previous weeks, increasing to 81.7% among people aged 18 years and older and 79.0% among those aged 12 years and older.

RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today.  The open data now includes vaccination turnout and coverage by municipality for three age groups.

Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.

Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.